Smiths Group plc (LON:SMIN) insider Andrew Reynolds Smith sold 28,427 shares of the firm’s stock in a transaction that occurred on Friday, June 30th. The stock was sold at an average price of GBX 1,593 ($20.26), for a total transaction of £452,842.11 ($575,988.44).

Smiths Group plc (LON SMIN) opened at 1610.00 on Monday. The firm’s market cap is GBX 6.37 billion. Smiths Group plc has a 1-year low of GBX 1,115.00 and a 1-year high of GBX 1,685.00. The stock’s 50 day moving average price is GBX 1,609.47 and its 200 day moving average price is GBX 1,553.69.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/07/03/insider-selling-smiths-group-plc-smin-insider-sells-28427-shares-of-stock.html.

A number of equities analysts have recently issued reports on the stock. Deutsche Bank AG restated a “buy” rating and set a GBX 1,750 ($22.26) target price on shares of Smiths Group plc in a research report on Wednesday, May 3rd. J P Morgan Chase & Co restated an “overweight” rating and set a GBX 1,730 ($22.00) target price on shares of Smiths Group plc in a research report on Wednesday, May 3rd. HSBC Holdings plc raised their target price on shares of Smiths Group plc from GBX 1,700 ($21.62) to GBX 1,900 ($24.17) and gave the stock a “buy” rating in a research report on Thursday, April 6th. Goldman Sachs Group, Inc. (The) raised their target price on shares of Smiths Group plc from GBX 1,800 ($22.89) to GBX 1,850 ($23.53) and gave the stock a “buy” rating in a research report on Monday, April 10th. Finally, Royal Bank Of Canada raised their target price on shares of Smiths Group plc from GBX 1,700 ($21.62) to GBX 1,750 ($22.26) and gave the stock an “outperform” rating in a research report on Thursday, March 30th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of GBX 1,582.08 ($20.12).

About Smiths Group plc

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.

Receive News & Ratings for Smiths Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group plc and related companies with MarketBeat.com's FREE daily email newsletter.